REGenableMED is an ESRC-funded project examining the dynamics of innovation within the field of regenerative medicine. Using a mixed-methods social science approach, the project will undertake a detailed analysis of the interplay between business models, measures of clinical utility, patterns of regulatory oversight and clinical workflows within healthcare settings. The results of the research will inform strategies aimed at facilitating the responsible development of effective and useful regenerative medicine products and services.
The project uses the notion of institutional readiness as an analytical starting point. The progress of innovation projects is often understood in terms of technology readiness: the extent to which the innovative technology has matured and is 'ready' to be put to use. Yet successful innovation also depends upon what could be called institutional readiness, or the capacity and willingness of key pre-existing organisations and inter-organisational structures to adopt, respond to and utilise novel technologies. Institutional readiness is particularly significant in the developing field of regenerative medicine (RM). For RM to live up to its promise of revolutionising patient care, emerging products must somehow be accommodated within pre-existing regulatory and healthcare organisations that are accustomed to dealing with more conventional medicinal products and services.
The REGenableMED project thus examines the ways in which relevant institutions and agencies are 'readying' themselves for regenerative medicine, and the various factors that enable and hinder institutional 'readiness'. By doing this, the project will produce applicable findings that can inform healthcare policy and commercial strategies aimed at the responsible development and adoption of novel RM therapies.
ESRC Grant Ref: ES/L002779/1
Total Value of the Award: £1,547,370
Duration: 3 years (May 1 2014-April 30 2017)